86,717 Shares in Xylem Inc. $XYL Bought by Commerzbank Aktiengesellschaft FI

Commerzbank Aktiengesellschaft FI acquired a new stake in Xylem Inc. (NYSE:XYLFree Report) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 86,717 shares of the industrial products company’s stock, valued at approximately $10,251,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of XYL. AQR Capital Management LLC boosted its stake in shares of Xylem by 14.4% in the 1st quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock valued at $3,645,000 after purchasing an additional 3,900 shares in the last quarter. NewEdge Advisors LLC increased its position in Xylem by 3.3% during the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock worth $496,000 after purchasing an additional 132 shares in the last quarter. Empowered Funds LLC lifted its stake in Xylem by 56.1% in the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock valued at $1,037,000 after purchasing an additional 3,120 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in Xylem by 97.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company’s stock valued at $1,442,000 after purchasing an additional 5,509 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in Xylem by 114.0% in the second quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company’s stock valued at $154,000 after buying an additional 635 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Xylem Trading Down 1.7%

Shares of NYSE XYL opened at $117.59 on Tuesday. The firm has a 50 day moving average price of $117.63 and a two-hundred day moving average price of $120.33. The stock has a market cap of $27.46 billion, a P/E ratio of 28.00, a price-to-earnings-growth ratio of 1.66 and a beta of 1.02. Xylem Inc. has a 52-week low of $105.29 and a 52-week high of $154.27. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.24 and a current ratio of 1.61.

Xylem (NYSE:XYLGet Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The industrial products company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.34 by $0.12. Xylem had a net margin of 11.15% and a return on equity of 11.77%. The company had revenue of $2.34 billion for the quarter, compared to analyst estimates of $2.34 billion. During the same quarter in the previous year, the business earned $1.26 earnings per share. Xylem’s revenue was up 1.5% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. As a group, equities analysts forecast that Xylem Inc. will post 5.67 EPS for the current year.

Xylem Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th will be issued a dividend of $0.43 per share. The ex-dividend date of this dividend is Thursday, August 27th. This represents a $1.72 annualized dividend and a yield of 1.5%. Xylem’s payout ratio is presently 40.95%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on XYL. Weiss Ratings reiterated a “hold (c)” rating on shares of Xylem in a report on Wednesday, August 5th. Oppenheimer cut their price objective on Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a report on Wednesday, April 29th. Stifel Nicolaus boosted their price objective on Xylem from $157.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, July 29th. Robert W. Baird upped their target price on Xylem from $163.00 to $165.00 and gave the stock an “outperform” rating in a report on Wednesday, July 29th. Finally, UBS Group increased their target price on Xylem from $135.00 to $138.00 and gave the company a “neutral” rating in a research report on Thursday. Nine research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $154.23.

Check Out Our Latest Report on Xylem

Xylem Company Profile

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Recommended Stories

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.